A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)

Clinical trial NCT07705607 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07705607
Sponsor: Merck Sharp & Dohme LLC
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Retinopathy Macular Edema

Start date: 2026-09-30
Primary completion: 2028-11-30
Enrollment: 1104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.